CURE DHDDS
The main activities of the charity are to relieve the needs of those affected by DHDDS Disease, to support families affected by DHDDS mutations and drive research into them. We achieve this by providing the latest information on the condition to families and health professionals, providing funds for further scientific research and raising awareness of the disease.
Financial health, per its FY2025 accounts
The accounts state that the charity held unrestricted reserves of £221,662 at the end of the financial year, significantly exceeding its stated policy target of £10,000 - £12,000. The charity reported total receipts of £131,495 and total payments of £69,071, resulting in a net surplus that strengthened its cash position.
What the accounts disclose
“A1 Receipts Donations Interest”
“we would look to hold a general reserve in the range £10,000 - £12,000 to cover unfunded committed costs for the next 6 months.”
Trustees
- CHARLES DIXON
- Ian Roberts
- Katie McCombe
- Louise Townley
- Penny Brogan
- Victoria Allan
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £131k | £69k |
| 31/03/2024 | £236k | £77k |
Common questions
Is CURE DHDDS financially healthy?
Per its FY2025 accounts: The accounts state that the charity held unrestricted reserves of £221,662 at the end of the financial year, significantly exceeding its stated policy target of £10,000 - £12,000. The charity reported total receipts of £131,495 and total payments of £69,071, resulting in a net surplus that strengthened its cash position. Its FY2025 accounts were independently examined.
Who funds CURE DHDDS?
Funders whose own accounts filings name CURE DHDDS as a grant recipient include THE MELETE FOUNDATION, THE HISCOX FOUNDATION.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| THE MELETE FOUNDATION | FY2023 | £5k | |
| THE MELETE FOUNDATION | FY2024 | £5k | |
| THE HISCOX FOUNDATION | FY2025 | £1k |